Clinical value of transurethral second resection of bladder tumor: Systematic review

Urology

Volumn 84, Issue 4, 2014, Pages 881-885

  Dobruch, Jakub ^a,b   Borówka, Andrzej ^a   Herr, Harry W ^c  

^a Postgraduate Medical Education Center   (Poland)

^b Young Academic Urologists of European Association of Urology Bladder Cancer Group   (Poland)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BLADDER CANCER; BLEEDING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; EARLY INTERVENTION; EPIDIDYMITIS; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; META ANALYSIS; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REOPERATION; REVIEW; SURGICAL APPROACH; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; URINE RETENTION; CLINICAL TRIAL (TOPIC); PROCEDURES; URETHRA; URINARY BLADDER NEOPLASMS;

CLINICAL TRIALS AS TOPIC; CYSTECTOMY; HUMANS; PROSPECTIVE STUDIES; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 84922012904     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.06.005     Document Type: Article

References (15)

1. K.T. Adiyat, D. Katkoori, and C.T. Soloway "Complete transurethral resection of bladder tumor": are the guidelines being followed? Urology 75 2010 365 367
2. J. Dobruch, and H.W. Herr Should all patients receive single chemotherapeutic agent instillation after bladder tumor resection (TURBT)? BJU Int 2 2009 170 174
3. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement Open Med 3 2009 e123 e130
4. J.P. Sfakianos, P.H. Kim, and A.A. Hakimi The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin J Urol 191 2014 341 345
5. W. Kim, C. Song, and S. Park Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor J Endourol 26 2012 1059 1064
6. R.T. Divrik, A.F. Sahin, and U. Yildirim Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial Eur Urol 58 2010 185 190
7. R.T. Divrik, U. Yildirim, and F. Zorlu The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial J Urol 175 2006 1641 1644
8. M.H. Ali, I.Y. Ismail, and A. Eltobgy Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer J Endourol 24 2010 2047 2050
9. T. Divrik, U. Yildirim, and A.S. Eroʇlu Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 175 2006 1258 1261
10. H.W. Herr The value of a second transurethral resection in evaluating patients with bladder tumors J Urol 162 1999 74 76
11. H. Mostafid, and M. Brausi Measuring and improving the quality of transurethral resection for bladder tumour (TURBT) BJU Int 109 2012 1579 1582
12. H.W. Herr Conservative management of muscle-infiltrating bladder cancer: prospective experience J Urol 138 1987 1162 1163
13. T. Hara, J. Nishijima, and Y. Miyachika Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation Jpn J Clin Oncol 41 2011 902 907
14. M.S. Soloway Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder Urol Oncol 24 2006 58 61
15. S.M. Donat, A. North, and G. Dalbagni Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm J Urol 171 2004 636 639